Works matching AU Karlin, Lionel

Results: 75
    1

    Diagnostic value of the wnt target and cancer-associated blood biomarker hPG80: ONCOPRO case-control prospective study.

    Published in:
    Biomarker Research, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40364-025-00793-z
    By:
    • You, Benoit;
    • Couraud, Sebastien;
    • Ceruse, Philippe;
    • Badet, Lionel;
    • Paparel, Philippe;
    • Durand, Alice;
    • Guillet, Marielle;
    • Merle, Philippe;
    • Lescuyer, Gaelle;
    • Philip, Charles-André;
    • Ducray, Francois;
    • Pioche, Mathieu;
    • Karlin, Lionel;
    • Lifante, Jean-Christophe;
    • Glehen, Olivier;
    • Bolze, Pierre-Adrien;
    • Chauvenet, Marion;
    • Langlois-Jacques, Carole;
    • Subtil, Fabien;
    • Piecyk, Marie
    Publication type:
    Article
    2

    Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE‐MM2 trial.

    Published in:
    EJHaem, 2023, v. 4, n. 4, p. 995, doi. 10.1002/jha2.759
    By:
    • Richardson, Paul G.;
    • Facon, Thierry;
    • Venner, Christopher P.;
    • Bahlis, Nizar J.;
    • Offner, Fritz;
    • White, Darrell;
    • Karlin, Lionel;
    • Benboubker, Lotfi;
    • Voog, Eric;
    • Yoon, Sung‐Soo;
    • Suzuki, Kenshi;
    • Shibayama, Hirohiko;
    • Zhang, Xiaoquan;
    • Villarreal, Miguel;
    • Twumasi‐Ankrah, Philip;
    • Labotka, Richard;
    • Rifkin, Robert M.;
    • Lonial, Sagar;
    • Kumar, Shaji K.;
    • Rajkumar, S. Vincent
    Publication type:
    Article
    3

    Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma.

    Published in:
    Advances in Therapy, 2024, v. 41, n. 4, p. 1576, doi. 10.1007/s12325-024-02797-x
    By:
    • Einsele, Hermann;
    • Moreau, Philippe;
    • Bahlis, Nizar;
    • Bhutani, Manisha;
    • Vincent, Laure;
    • Karlin, Lionel;
    • Perrot, Aurore;
    • Goldschmidt, Hartmut;
    • van de Donk, Niels W. C. J.;
    • Ocio, Enrique M.;
    • Martinez-Lopez, Joaquin;
    • Rodríguez-Otero, Paula;
    • Dytfeld, Dominik;
    • Diels, Joris;
    • Strulev, Vadim;
    • Haddad, Imene;
    • Renaud, Thomas;
    • Ammann, Eric;
    • Cabrieto, Jedelyn;
    • Perualila, Nolen
    Publication type:
    Article
    4

    Comparative Effectiveness of Teclistamab Versus Real-World Physician's Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma.

    Published in:
    Advances in Therapy, 2024, v. 41, n. 2, p. 696, doi. 10.1007/s12325-023-02738-0
    By:
    • Moreau, Philippe;
    • Mateos, María-Victoria;
    • Gonzalez Garcia, Maria Esther;
    • Einsele, Hermann;
    • De Stefano, Valerio;
    • Karlin, Lionel;
    • Lindsey-Hill, Joanne;
    • Besemer, Britta;
    • Vincent, Laure;
    • Kirkpatrick, Suriya;
    • Delforge, Michel;
    • Perrot, Aurore;
    • van de Donk, Niels W. C. J.;
    • Pawlyn, Charlotte;
    • Manier, Salomon;
    • Leleu, Xavier;
    • Martinez-Lopez, Joaquin;
    • Ghilotti, Francesca;
    • Diels, Joris;
    • Morano, Raúl
    Publication type:
    Article
    5

    Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma.

    Published in:
    Advances in Therapy, 2023, v. 40, n. 5, p. 2412, doi. 10.1007/s12325-023-02480-7
    By:
    • Moreau, Philippe;
    • van de Donk, Niels W. C. J.;
    • Delforge, Michel;
    • Einsele, Hermann;
    • De Stefano, Valerio;
    • Perrot, Aurore;
    • Besemer, Britta;
    • Pawlyn, Charlotte;
    • Karlin, Lionel;
    • Manier, Salomon;
    • Leleu, Xavier;
    • Weisel, Katja;
    • Ghilotti, Francesca;
    • Diels, Joris;
    • Elsada, Ahmed;
    • Morano, Raul;
    • Strulev, Vadim;
    • Pei, Lixia;
    • Kobos, Rachel;
    • Smit, Jennifer
    Publication type:
    Article
    6

    Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. 264, doi. 10.1002/ajh.26785
    By:
    • Dumontet, Charles;
    • Demangel, Delphine;
    • Galia, Perrine;
    • Karlin, Lionel;
    • Roche, Laurent;
    • Fauvernier, Mathieu;
    • Golfier, Camille;
    • Laude, Marie‐Charlotte;
    • Leleu, Xavier;
    • Rodon, Philippe;
    • Roussel, Murielle;
    • Azaïs, Isabelle;
    • Doyen, Chantal;
    • Slama, Borhane;
    • Manier, Salomon;
    • Decaux, Olivier;
    • Pertesi, Maroulio;
    • Beaumont, Marie;
    • Caillot, Denis;
    • Boyle, Eileen M.
    Publication type:
    Article
    7

    Commercial anti‐CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 11, p. 1324, doi. 10.1002/ajh.25951
    By:
    • Sesques, Pierre;
    • Ferrant, Emmanuelle;
    • Safar, Violaine;
    • Wallet, Florent;
    • Tordo, Jérémie;
    • Dhomps, Anthony;
    • Karlin, Lionel;
    • Brisou, Gabriel;
    • Vercasson, Marlène;
    • Hospital‐Gustem, Carole;
    • Schwiertz, Vérane;
    • Ranchon, Florence;
    • Rioufol, Catherine;
    • Choquet, Marion;
    • Sujobert, Pierre;
    • Ghergus, Dana;
    • Bouafia, Fadhela;
    • Golfier, Camille;
    • Lequeu, Helène;
    • Lazareth, Anne
    Publication type:
    Article
    8

    Apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot study.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 6, p. 635, doi. 10.1002/ajh.25459
    By:
    • Pegourie, Brigitte;
    • Karlin, Lionel;
    • Benboubker, Lotfi;
    • Orsini‐Piocelle, Frédérique;
    • Tiab, Mourad;
    • Auger‐Quittet, Sophie;
    • Rodon, Philippe;
    • Royer, Bruno;
    • Leleu, Xavier;
    • Bareau, Benoit;
    • Cliquennois, Manuel;
    • Fuzibet, Jean‐Gabriel;
    • Voog, Eric;
    • Belhadj‐Merzoug, Karim;
    • Decaux, Olivier;
    • Rey, Philippe;
    • Slama, Bohrane;
    • Leyronnas, Cecile;
    • Zarnitsky, Charles;
    • Boyle, Eileen
    Publication type:
    Article
    9

    Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01200-w
    By:
    • Malard, Florent;
    • Bobin, Arthur;
    • Labopin, Myriam;
    • Karlin, Lionel;
    • Frenzel, Laurent;
    • Roussel, Murielle;
    • Vignon, Marguerite;
    • Godet, Sophie;
    • Chalopin, Thomas;
    • Moyer, Perrine;
    • Chalayer, Emilie;
    • Orsini Piocelle, Frederique;
    • Mariette, Clara;
    • Croizier, Carolyne;
    • Sohn, Claudine;
    • Dib, Mamoun;
    • Le Calloch, Ronan;
    • Ali-Ammar, Nadia;
    • Loirat, Marion;
    • Benbrahim, Omar
    Publication type:
    Article
    10

    Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM.

    Published in:
    Blood Cancer Journal, 2024, v. 14, p. 1, doi. 10.1038/s41408-024-01200-w
    By:
    • Malard, Florent;
    • Bobin, Arthur;
    • Labopin, Myriam;
    • Karlin, Lionel;
    • Frenzel, Laurent;
    • Roussel, Murielle;
    • Vignon, Marguerite;
    • Godet, Sophie;
    • Chalopin, Thomas;
    • Moyer, Perrine;
    • Chalayer, Emilie;
    • Orsini Piocelle, Frederique;
    • Mariette, Clara;
    • Croizier, Carolyne;
    • Sohn, Claudine;
    • Dib, Mamoun;
    • Le Calloch, Ronan;
    • Ali-Ammar, Nadia;
    • Loirat, Marion;
    • Benbrahim, Omar
    Publication type:
    Article
    11

    Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00805-x
    By:
    • Moreau, Philippe;
    • Chari, Ajai;
    • Oriol, Albert;
    • Martinez-Lopez, Joaquin;
    • Haenel, Mathias;
    • Touzeau, Cyrille;
    • Ailawadhi, Sikander;
    • Besemer, Britta;
    • de la Rubia Comos, Javier;
    • Encinas, Cristina;
    • Mateos, Maria-Victoria;
    • Salwender, Hans;
    • Rodriguez-Otero, Paula;
    • Hulin, Cyrille;
    • Karlin, Lionel;
    • Sureda Balari, Anna;
    • Bargay, Joan;
    • Benboubker, Lotfi;
    • Rosiñol, Laura;
    • Tarantolo, Stefano
    Publication type:
    Article
    12

    Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

    Published in:
    2023
    By:
    • Moreau, Philippe;
    • Chari, Ajai;
    • Oriol, Albert;
    • Martinez-Lopez, Joaquin;
    • Haenel, Mathias;
    • Touzeau, Cyrille;
    • Ailawadhi, Sikander;
    • Besemer, Britta;
    • de la Rubia Comos, Javier;
    • Encinas, Cristina;
    • Mateos, Maria-Victoria;
    • Salwender, Hans;
    • Rodriguez-Otero, Paula;
    • Hulin, Cyrille;
    • Karlin, Lionel;
    • Sureda Balari, Anna;
    • Bargay, Joan;
    • Benboubker, Lotfi;
    • Rosiñol, Laura;
    • Tarantolo, Stefano
    Publication type:
    Letter
    13

    Genetically determined telomere length and multiple myeloma risk and outcome.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 4, p. 1, doi. 10.1038/s41408-021-00462-y
    By:
    • Giaccherini, Matteo;
    • Macauda, Angelica;
    • Orciuolo, Enrico;
    • Rymko, Marcin;
    • Gruenpeter, Karolina;
    • Dumontet, Charles;
    • Raźny, Malgorzata;
    • Moreno, Victor;
    • Buda, Gabriele;
    • Beider, Katia;
    • Varkonyi, Judit;
    • Avet-Loiseau, Hervé;
    • Martinez-Lopez, Joaquín;
    • Marques, Herlander;
    • Watek, Marzena;
    • Sarasquete, Maria Eugenia;
    • Andersen, Vibeke;
    • Karlin, Lionel;
    • Suska, Anna;
    • Kruszewski, Marcin
    Publication type:
    Article
    14

    Clinical and biological features of t(4;14) multiple myeloma: a prospective study.

    Published in:
    Leukemia & Lymphoma, 2011, v. 52, n. 2, p. 238, doi. 10.3109/10428194.2010.537795
    By:
    • Karlin, Lionel;
    • Soulier, Jean;
    • Chandesris, Olivia;
    • Choquet, Sylvain;
    • Belhadj, Karim;
    • Macro, Margaret;
    • Bouscary, Didier;
    • Porcher, Raphael;
    • Ghez, David;
    • Malphettes, Marion;
    • Asli, Bouchra;
    • Brouet, Jean Claude;
    • Bories, Jean Christophe;
    • Hermine, Olivier;
    • Fermand, Jean Paul;
    • Arnulf, Bertrand
    Publication type:
    Article
    15
    16
    17

    P979: PATIENT‐REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL‐WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE‐CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970820.69075.8f
    By:
    • Moreau, Philippe;
    • van de Donk, Niels W.C.J.;
    • Delforge, Michel;
    • Einsele, Hermann;
    • De Stefano, Valerio;
    • Perrot, Aurore;
    • Besemer, Britta;
    • Pawlyn, Charlotte;
    • Karlin, Lionel;
    • Manier, Salomon;
    • Leleu, Xavier;
    • Thilakarathne, Pushpike;
    • Diels, Joris;
    • Gries, Katharine;
    • Erler‐Yates, Nichola;
    • van Nimwegen, Kirsten;
    • Morano, Raúl;
    • Strulev, Vadim;
    • Haddad, Imene;
    • Kobos, Rachel
    Publication type:
    Article
    18

    P923: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS REAL‐WORLD PHYSICIAN’S CHOICE OF TREATMENT IN LOCOMMOTION AND MOMMENT FOR PATIENTS WITH TRIPLE‐CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970596.51835.28
    By:
    • Einsele, Hermann;
    • Moreau, Philippe;
    • Bahlis, Nizar J;
    • Bhutani, Manisha;
    • Vincent, Laure;
    • Karlin, Lionel;
    • Perrot, Aurore;
    • Goldschmidt, Hartmut;
    • van de Donk, Niels W.C.J.;
    • Ocio, Enrique;
    • Martinez‐Lopez, Joaquín;
    • Rodríguez‐Otero, Paula;
    • Dytfeld, Dominik;
    • Diels, Joris;
    • Strulev, Vadim;
    • Haddad, Imene;
    • Renaud, Thomas;
    • Ammann, Eric;
    • Cabrieto, Jedelyn;
    • Perualila, Nolen
    Publication type:
    Article
    19
    20

    P881: DURABILITY OF RESPONSES WITH BIWEEKLY DOSING OF TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA ACHIEVING A CLINICAL RESPONSE IN THE MAJESTEC‐1 STUDY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970428.90600.b0
    By:
    • Bhutani, Manisha;
    • Garfall, Alfred;
    • Uttervall, Katarina;
    • Usmani, Saad Z;
    • Karlin, Lionel;
    • Benboubker, Lotfi;
    • Nahi, Hareth;
    • San Miguel, Jesús;
    • Trancucci, Danielle;
    • Qi, Keqin;
    • Stephenson, Tara;
    • Perales‐Puchalt, Alfredo;
    • Chastain, Katherine;
    • Chari, Ajai
    Publication type:
    Article
    21

    P876: ANCHOR (OP‐104): MELFLUFEN PLUS DEXAMETHASONE AND DARATUMUMAB OR BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA—FINAL EFFICACY AND SAFETY RESULTS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970408.28426.27
    By:
    • Miguel, Enrique Maria Ocio San;
    • Efebera, Yvonne A.;
    • Hájek, Roman;
    • Straub, Jan;
    • Maisnar, Vladimir;
    • Eveillard, Jean‐Richard;
    • Karlin, Lionel;
    • Mateos, Maria‐Victoria;
    • Oriol, Albert;
    • Ribrag, Vincent;
    • Richardson, Paul;
    • Norin, Stefan;
    • Obermüller, Jakob;
    • Bakker, Nicolaas A.;
    • Pour, Ludek
    Publication type:
    Article
    22

    P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES.

    Published in:
    2023
    By:
    • Manier, Salomon;
    • Lesokhin, Alexander;
    • Mohty, Mohamad;
    • Niesvizky, Ruben;
    • Maisel, Christopher;
    • Arnulf, Bertrand;
    • Larson, Sarah M.;
    • Nina Varshavsky-Yanovsky, Asya;
    • Leleu, Xavier;
    • Karlin, Lionel;
    • Vesole, David H.;
    • Bahlis, Nizar J;
    • Fernandez de Larrea, Carlos;
    • Raje, Noopur;
    • Leip, Eric;
    • Sullivan, Sharon T.;
    • Elmeliegy, Mohamed;
    • Viqueira, Andrea;
    • Nooka, Ajay
    Publication type:
    Abstract
    23

    End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy.

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1436587
    By:
    • Sesques, Pierre;
    • Karlin, Lionel;
    • Massy, Emmanuel;
    • Maarek, Alizée;
    • Aussedat, Guillaume;
    • Lazareth, Anne;
    • Golfier, Camille;
    • Bouafia-Sauvy, Fadhela;
    • Lequeu, Helene;
    • Ghergus, Dana;
    • Safar, Violaine;
    • Ferrant, Emmanuelle;
    • Bachy, Emmanuel;
    • Ghesquières, Hervé;
    • Confavreux, Cyrille B.;
    • Demangel, Delphine;
    • Perrial, Emeline;
    • Dumontet, Charles
    Publication type:
    Article
    24
    25
    26

    Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective study.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 3, p. 599, doi. 10.1080/10428194.2021.1998483
    By:
    • Aussedat, Guillaume;
    • Maucort-Boulch, Delphine;
    • Rey, Philippe;
    • Safar, Violaine;
    • Karlin, Lionel;
    • Elsensohn, Mad Helenie;
    • Bachy, Emmanuel;
    • Lebras, Laure;
    • Favier, Bertrand;
    • Vantard, Nicolas;
    • Ghergus, Dana;
    • Golfier, Camille;
    • Sesques, Pierre;
    • Lazareth, Anne;
    • Lequeu, Hélène;
    • Ferrant, Emmanuelle;
    • Salles, Gilles;
    • Nicolas-Virelizier, Emmanuelle;
    • Ghesquieres, Hervé
    Publication type:
    Article
    27

    Netrin-1 expression and targeting in multiple myeloma.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 2, p. 395, doi. 10.1080/10428194.2021.1984459
    By:
    • Fahed, David;
    • Chettab, AbdelKamel;
    • Mathe, Doriane;
    • Denis, Morgane;
    • Traverse-Glehen, Alexandra;
    • Karlin, Lionel;
    • Perrial, Emeline;
    • Dumontet, Charles
    Publication type:
    Article
    28

    Health-related quality of life results from the IFM 2009 trial: treatment with lenalidomide, bortezomib, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 6, p. 1323, doi. 10.1080/10428194.2020.1719091
    By:
    • Roussel, Murielle;
    • Hebraud, Benjamin;
    • Hulin, Cyrille;
    • Perrot, Aurore;
    • Caillot, Denis;
    • Stoppa, Anne-Marie;
    • Macro, Margaret;
    • Escoffre, Martine;
    • Arnulf, Bertrand;
    • Belhadj, Karim;
    • Karlin, Lionel;
    • Garderet, Laurent;
    • Facon, Thierry;
    • Guo, Shien;
    • Weng, Josh;
    • Dhanasiri, Sujith;
    • Leleu, Xavier;
    • Moreau, Philippe;
    • Attal, Michel
    Publication type:
    Article
    29

    Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 3, p. 583, doi. 10.1080/10428194.2017.1339876
    By:
    • Fouquet, Guillemette;
    • Snell, Kym IE;
    • Guidez, Stéphanie;
    • Schraen, Susanna;
    • Boyle, Eileen;
    • Renaud, Loïc;
    • Desmier, Déborah;
    • Machet, Antoine;
    • Moya, Niels;
    • Systchenko, Thomas;
    • Gruchet, Cécile;
    • Decaux, Olivier;
    • Arnulf, Bertrand;
    • Fohrer, Cécile;
    • Richez, Valentine;
    • Kolb, Brigitte;
    • Macro, Margaret;
    • Karlin, Lionel;
    • Royer, Bruno;
    • Pegourie, Brigitte
    Publication type:
    Article
    30
    31

    Pregnancy and multiple myeloma are not antinomic.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 12, p. 2738, doi. 10.3109/10428194.2013.786069
    By:
    • Brisou, Gabriel;
    • Bouafia-Sauvy, Fadhela;
    • Karlin, Lionel;
    • Lebras, Laure;
    • Salles, Gilles;
    • Coiffier, Bertrand;
    • Michallet, Anne-Sophie
    Publication type:
    Article
    32

    Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.

    Published in:
    British Journal of Haematology, 2014, v. 164, n. 5, p. 659, doi. 10.1111/bjh.12675
    By:
    • Sarkozy, Clémentine;
    • Baseggio, Lucile;
    • Feugier, Pierre;
    • Callet‐Bauchu, Evelyne;
    • Karlin, Lionel;
    • Seymour, John F.;
    • Lebras, Laure;
    • Michallet, Anne‐Sophie;
    • Offner, Fritz;
    • Dumas, Olivier;
    • Traverse‐Glehen, Alexandra;
    • Ffrench, Martine;
    • Lopez‐Guillermo, Armando;
    • Berger, Françoise;
    • Coiffier, Bertrand;
    • Felman, Pascale;
    • Salles, Gilles
    Publication type:
    Article
    33
    34
    35

    Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3297
    By:
    • Lan, Caroline Le;
    • Belot, Aurélien;
    • Golfier, Camille;
    • Audin, Bérénice;
    • Sesques, Pierre;
    • Bernier, Adeline;
    • Safar, Violaine;
    • Ferrant, Emmanuelle;
    • Lazareth, Anne;
    • Lequeu, Hélène;
    • Karlin, Lionel;
    • Ghergus, Dana;
    • Maarek, Alizée;
    • Aussedat, Guillaume;
    • Idlhaj, Maryam;
    • Salles, Gilles;
    • Cherblanc, Fanny;
    • Bachy, Emmanuel;
    • Ghesquieres, Hervé
    Publication type:
    Article
    36
    37

    Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes.

    Published in:
    2018
    By:
    • Filliatre‐clement, Lauriane;
    • Maucort‐Boulch, Delphine;
    • Bourbon, Estelle;
    • Karlin, Lionel;
    • Safar, Violaine;
    • Bachy, Emmanuel;
    • Sesques, Pierre;
    • Ferrant, Emmanuelle;
    • Bouafia, Fadela;
    • Lazareth, Anne;
    • Ghergus, Dana;
    • Coiffier, Bertrand;
    • Traverse Glehen, Alexandra;
    • Salles, Gilles;
    • Ghesquieres, Hervé;
    • Sarkozy, Clémentine;
    • Filliatre-Clement, Lauriane;
    • Maucort-Boulch, Delphine
    Publication type:
    journal article
    38
    39
    40
    41
    42

    Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma.

    Published in:
    2018
    By:
    • Fouquet, Guillemette;
    • Petillon, Marie Odile;
    • Facon, Thierry;
    • Kolb, Brigitte;
    • Stoppa, Anne-Marie;
    • Brechiniac, Sabine;
    • Rodon, Philippe;
    • Dib, Mamoun;
    • Tiab, Mourad;
    • Richez, Valentine;
    • Araujo, Carla;
    • Wetterwald, Marc;
    • Garderet, Laurent;
    • Karlin, Lionel;
    • Royer, Bruno;
    • Perrot, Aurore;
    • Benboubker, Lotfi;
    • Decaux, Olivier;
    • Escoffre-Barbe, Martine;
    • Moreau, Philippe
    Publication type:
    journal article
    43

    Real‐World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated Before the Era of Anti‐CD38 Antibodies: The EMMY Cohort From 2017 to 2020.

    Published in:
    Cancer Medicine, 2025, v. 14, n. 6, p. 1, doi. 10.1002/cam4.70619
    By:
    • Vincent, Laure;
    • Decaux, Olivier;
    • Perrot, Aurore;
    • Royer, Bruno;
    • Chalopin, Thomas;
    • Bobin, Arthur;
    • Macro, Margaret;
    • Caillot, Denis;
    • Karlin, Lionel;
    • Jacquet, Caroline;
    • Sonntag, Cécile;
    • Mohty, Mohamad;
    • Frenzel, Laurent;
    • Jaccard, Arnaud;
    • Manier, Salomon;
    • Sanhes, Laurence;
    • Chaoui, Driss;
    • Moreau, Philippe;
    • Garlantézec, Ronan;
    • Texier, Nathalie
    Publication type:
    Article
    44

    Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 study.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 9, p. 10254, doi. 10.1002/cam4.5753
    By:
    • Lesokhin, Alexander;
    • LeBlanc, Richard;
    • Dimopoulos, Meletios A.;
    • Capra, Marcelo;
    • Carlo‐Stella, Carmelo;
    • Karlin, Lionel;
    • Castilloux, Jean‐Francois;
    • Forsberg, Peter;
    • Parmar, Gurdeep;
    • Tosikyan, Axel;
    • Pour, Ludek;
    • Ribrag, Vincent;
    • Ribolla, Rossella;
    • Abdallah, Al‐Ola;
    • Le Roux, Nadia;
    • Dong, Liyan;
    • van de Velde, Helgi;
    • Mayrargue, Laurent;
    • Lépine, Lucie;
    • Macé, Sandrine
    Publication type:
    Article
    45
    46

    Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study.

    Published in:
    Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01188-x
    By:
    • Wang, Michael;
    • Ramchandren, Radhakrishnan;
    • Chen, Robert;
    • Karlin, Lionel;
    • Chong, Geoffrey;
    • Jurczak, Wojciech;
    • Wu, Ka Lung;
    • Bishton, Mark;
    • Collins, Graham P.;
    • Eliadis, Paul;
    • Peyrade, Frédéric;
    • Lee, Yihua;
    • Eckert, Karl;
    • Neuenburg, Jutta K.;
    • Tam, Constantine S.
    Publication type:
    Article
    47

    Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial.

    Published in:
    Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01004-y
    By:
    • Kreitman, Robert J.;
    • Dearden, Claire;
    • Zinzani, Pier Luigi;
    • Delgado, Julio;
    • Robak, Tadeusz;
    • le Coutre, Philipp D.;
    • Gjertsen, Bjørn T.;
    • Troussard, Xavier;
    • Roboz, Gail J.;
    • Karlin, Lionel;
    • Gladstone, Douglas E.;
    • Kuptsova-Clarkson, Nataliya;
    • Liu, Shiyao;
    • Patel, Priti;
    • Rotolo, Federico;
    • Mitry, Emmanuel;
    • Pastan, Ira;
    • Giles, Francis
    Publication type:
    Article
    48

    B-Cell and T-Cell Phenotypes in CVID Patients Correlate with the Clinical Phenotype of the Disease.

    Published in:
    Journal of Clinical Immunology, 2010, v. 30, n. 5, p. 746, doi. 10.1007/s10875-010-9424-3
    By:
    • Mouillot, Gaël;
    • Carmagnat, Maryvonnick;
    • Gérard, Laurence;
    • Garnier, Jean-Luc;
    • Fieschi, Claire;
    • Vince, Nicolas;
    • Karlin, Lionel;
    • Viallard, Jean-François;
    • Jaussaud, Roland;
    • Boileau, Julien;
    • Donadieu, Jean;
    • Gardembas, Martine;
    • Schleinitz, Nicolas;
    • Suarez, Felipe;
    • Hachulla, Eric;
    • Delavigne, Karen;
    • Morisset, Martine;
    • Jacquot, Serge;
    • Just, Nicolas;
    • Galicier, Lionel
    Publication type:
    Article
    49

    Immunoglobulin Dosage and Switch from Intravenous to Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Hypogammaglobulinemia: Decreasing Dosage Does Not Alter Serum IgG Levels.

    Published in:
    Journal of Clinical Immunology, 2010, v. 30, n. 4, p. 602, doi. 10.1007/s10875-010-9417-2
    By:
    • Thépot, Sylvain;
    • Malphettes, Marion;
    • Gardeur, Anaëlle;
    • Galicier, Lionel;
    • Asli, Bouchra;
    • Karlin, Lionel;
    • Gérard, Laurence;
    • Laumont, Richard;
    • Doize, Marie-Laure;
    • Arnulf, Bertrand;
    • Fieschi, Claire;
    • Bengoufa, Djaouïda;
    • Oksenhendler, Eric
    Publication type:
    Article
    50